BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6203854)

  • 1. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
    Kurman RJ; Ganjei P; Nadji M
    Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins.
    Miettinen M; Wahlstrom T; Virtanen I; Talerman A; Astengo-Osuna C
    Am J Surg Pathol; 1985 Sep; 9(9):640-51. PubMed ID: 2996374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
    Calame J; Bosman FT; Schaberg A; Louwerens JW
    Int J Gynecol Pathol; 1984; 3(1):92-100. PubMed ID: 6203857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of primary and secondary germ cell tumors.
    Van Cangh PJ; Ferrant A; Ninane J; Humblet Y; Deckers C
    Prog Clin Biol Res; 1985; 203():127-38. PubMed ID: 2421326
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of serum tumor markers in the management of patients with malignancy.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
    Obata N; Kodama S; Hando T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokeratins in Sertoli-Leydig cell tumors of the ovary.
    Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Nishino T; Saito J; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1937-8. PubMed ID: 2414379
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
    Tanimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of immunocytochemistry to gynaecological pathology.
    Kurman RJ
    Clin Obstet Gynaecol; 1984 Apr; 11(1):5-23. PubMed ID: 6201314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic monitoring of cervical carcinoma.
    Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
    Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
    Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers: how useful are they?
    McIntire KR
    Hosp Pract (Off Ed); 1984 Dec; 19(12):55-68. PubMed ID: 6209292
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
    Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
    Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
    Yoshimoto T; Higashino K; Hada T; Tamura S; Nakanishi K; Mitsunobu M; Uematsu K; Matsuoka T; Taketa K
    Cancer; 1987 Dec; 60(11):2744-50. PubMed ID: 2445464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.